Xiaoyue Sun, Xinyi Chen, Fandi Zhang, Xin Wu, Lei Liu, Jing Jing et al. Comparative Cost‐Effectiveness of First‐Line Immunotherapy‐Based Regimens for Advanced Triple‐Negative Breast Cancer. // Journal of Evidence-Based Medicine. – 2026. – DOI: 10.1111/jebm.70184. – URL: https://onlinelibrary.wiley.com/doi/10.1111/jebm.70184?af=R
Xiaoyue Sun, Xinyi Chen, Fandi Zhang, Xin Wu, Lei Liu, Jing Jing, Yuli Luo, Jiaqi Han, & Jie Lan (2026). Comparative Cost‐Effectiveness of First‐Line Immunotherapy‐Based Regimens for Advanced Triple‐Negative Breast Cancer. Journal of Evidence-Based Medicine. https://doi.org/10.1111/jebm.70184
Xiaoyue Sun, et al. “Comparative Cost‐Effectiveness of First‐Line Immunotherapy‐Based Regimens for Advanced Triple‐Negative Breast Cancer.” Journal of Evidence-Based Medicine, 2026. doi:10.1111/jebm.70184.
@article{Sun2026,
title = {Comparative Cost‐Effectiveness of First‐Line Immunotherapy‐Based Regimens for Advanced Triple‐Negative Breast Cancer},
author = {Sun, Xiaoyue and Chen, Xinyi and Zhang, Fandi and Wu, Xin and Liu, Lei and Jing, Jing and Luo, Yuli and Han, Jiaqi and Lan, Jie},
journal = {Journal of Evidence-Based Medicine},
year = {2026},
doi = {10.1111/jebm.70184},
url = {https://onlinelibrary.wiley.com/doi/10.1111/jebm.70184?af=R}
}